Erschienen in:
25.04.2023 | Main topic
Chronic thromboembolic pulmonary hypertension—medical, interventional, and surgical therapy
verfasst von:
PD Dr. med. Christoph B. Wiedenroth, Diethard Pruefer, Miriam S. D. Adameit, Eckhard Mayer, Stefan Guth
Erschienen in:
Herz
|
Ausgabe 4/2023
Einloggen, um Zugang zu erhalten
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is an important late sequela of pulmonary embolism and a common form of pulmonary hypertension. Currently, three specific treatment modalities are available: pulmonary endarterectomy, balloon pulmonary angioplasty, and targeted medical therapy. The treatment decision depends mainly on the exact localization of the underlying pulmonary arterial obstructions. Pulmonary endarterectomy is the gold standard treatment of CTEPH. For inoperable patients, riociguat and treprostinil are approved. In addition, interventional therapy is recommended if appropriate target lesions are proven. Evaluation and treatment of patients with CTEPH in experienced centers are mandatory.